The Influence of Additional Treatments on the Survival of Patients Undergoing Transarterial Radioembolization (TARE).

Patients with HCC Among the patients with HCC, the patients receiving TARE and additional treatment (n = 8) demonstrated a trend of a longer CSS than the HCC patients receiving only TARE, although this did not reach statistical significance (n = 15; 27.89 ± 3.1 vs. 17.69 ± 3.14 months; p = 0.15; Figure 2 ). 3.2.

also in 111,027 other papers

Given the existence of a statistical trend, we suppose that the lack of statistical significance for a longer CSS in HCC patients receiving additional treatments compared to patients receiving only TARE may be attributed to the limited number of the patient sample.

also in 2,798 other papers